Company Name
Connect Biopharma Holdings Ltd
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US2075231017
CIK:
0001835268
CUSIP:
207523101
Currency:
USD
Full Time Employees:
64
Phone:
877 245 2787
Website:
https://www.connectbiopharm.com
Fiscal Year End:
December
IPO Date:
Mar 19, 2021
Description:
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Address:
3580 Carmel Mountain Road, San Diego, CA, United States, 92130